Log in to save to my catalogue

Safety Evaluation of Oral Sirolimus in the Treatment of Childhood Diseases: A Systematic Review

Safety Evaluation of Oral Sirolimus in the Treatment of Childhood Diseases: A Systematic Review

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_69c790bdc4e245a6b7de60e2a1c129d9

Safety Evaluation of Oral Sirolimus in the Treatment of Childhood Diseases: A Systematic Review

About this item

Full title

Safety Evaluation of Oral Sirolimus in the Treatment of Childhood Diseases: A Systematic Review

Publisher

Switzerland: MDPI AG

Journal title

Children (Basel), 2022-08, Vol.9 (9), p.1295

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Background: Sirolimus, a mammalian target of rapamycin inhibitor, has been widely used in pediatric patients, but the safety of sirolimus in pediatric patients has not been well determined. Objective: The objective of this study was to systematically evaluate prospective studies reporting the safety of sirolimus in the treatment of childhood diseas...

Alternative Titles

Full title

Safety Evaluation of Oral Sirolimus in the Treatment of Childhood Diseases: A Systematic Review

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_69c790bdc4e245a6b7de60e2a1c129d9

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_69c790bdc4e245a6b7de60e2a1c129d9

Other Identifiers

ISSN

2227-9067

E-ISSN

2227-9067

DOI

10.3390/children9091295

How to access this item